Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Henan Lingrui Biopharmaceutical is a specialized subsidiary of the publicly traded Henan Lingrui Pharmaceutical Co., Ltd., based in Xinyang, China. The company primarily focuses on the development and large-scale production of biological products, with its flagship product being the Purified Vero Cell Rabies Vaccine for Human Use. It operates within the broader Lingrui Group, which is a leader in the Chinese transdermal patch market and traditional Chinese medicine. Henan Lingrui Biopharmaceutical maintains modern GMP-certified manufacturing facilities dedicated to ensuring the quality and supply of essential vaccines. The company plays a critical role in the group's strategic expansion into modern biotechnology and infectious disease prevention.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Henan Lingrui Biopharmaceutical.